InfoBedingungenDatenschutzKontakt
 
Wird aktualisiert
Beyond the Scale: The Ozempic Effect

Beyond the Scale: The Ozempic Effect

Drugwatch.com
Veröffentlicht: 2025-09-04
© Drugwatch.com
Beyond the Scale: The Ozempic Effect - QR Code
Gratis0%
7 Folgen
Audio
Anhören auf Apple Podcasts
Gratis0%
7 Folgen
Audio
Anhören auf Apple Podcasts
Veröffentlicht: 2025-09-04
© Drugwatch.com
Aktuelle Folge
Bonus Episode: Health Concerns Emerge for Saxenda, Victoza

Bonus Episode: Health Concerns Emerge for Saxenda, Victoza

In this special bonus episode, hosts Terry Turner and Christian Simmons revisit the topic of GLP-1 drugs to dive into emerging health concerns for Saxenda and Victoza. New research has uncovered a potential link between liraglutide, the active ingredien
Länge: 6:11
Abspielen
In this special bonus episode, hosts Terry Turner and Christian Simmons revisit the topic of GLP-1 drugs to dive into emerging health concerns for Saxenda and Victoza.
New research has uncovered a potential link between liraglutide, the active ingredient in those drugs, and permanent vision loss.
To better understand the impact of this issue, Terry and Christian once again speak with attorney Danielle Gold from Weitz & Luxenberg, who is working on vision loss cases involving GLP-1s.Learn more at ⁠Drugwatch.com⁠.
Folgen-ID: 1000724988722
GUID: 5ce509ce-1d2e-4778-bf5b-04054ebebf8e
Erscheinungs­datum: 4.9.2025, 14:50:16

Beschreibung

First identified in the 1970s, GLP-1 medications have shaped diabetes treatments. But in recent years, the use of these drugs to help with weight loss has been revolutionary while also raising questions on safety.
In Beyond the Scale: The Ozempic Effect, hosts Terry Turner and Christian Simmons share in-depth research and insight from experts to reveal how GLP-1 drugs are shaping health, economics, policy and beyond.

Feed-URL

https://anchor.fm/s/1060bd810/podcast/rss

Apple Podcasts: Kundenrezensionen

Kein Eintrag